ライフサイエンスコーパス: low birth weight

1 n vitro) and a clinically important outcome (low birth weight).

2 terine environment (e.g., individuals with a low birth weight).

3 timality (viz foetal loss, preterm birth and low birth weight).

4 other outcomes (small for gestational age or low birth weight).

5 4, 2.9), respectively, in the probability of low birth weight.

6 ong pregnancies complicated by stillbirth or low birth weight.

7 ated with adverse pregnancy outcomes such as low birth weight.

8 pregnancy is very large, is associated with low birth weight.

9 nly statistically significant (P = 0.05) for low birth weight.

10 with maternal anemia, placental malaria, or low birth weight.

11 m at risk of adverse birth outcomes, such as low birth weight.

12 rchidism and hypospadias are prematurity and low birth weight.

13 2 key perinatal outcomes, preterm birth and low birth weight.

14 elivery, intrauterine growth restriction and low birth weight.

15 ) has been associated with preterm birth and low birth weight.

16 are serious in terms of maternal anemia and low birth weight.

17 ons on maternal anemia, premature birth, and low birth weight.

18 strointestinal bleeding, or for infants with low birth weight.

19 significant reductions in preterm births and low birth weight.

20 opulation), where a quarter of newborns have low birth weight.

21 ly miscarriage, postpartum endometritis, and low birth weight.

22 ted in preterm birth and 333 of 5426 (6%) in low birth weight.

23 of placenta malaria, anemia at delivery, and low birth weight.

24 impairment in 11-year-old children with very low birth weight.

25 25 singleton full-term infants, 4 (3.2%) had low birth weights.

26 in pregnancy tended to increase the risk of low birth weights.

27 antenatal maternal smoking; 15% were born at low birth weights.

28 with nonsignificant decreases in the risk of low birth weight (0.68; .29-1.57) and fetal or neonatal

29 s [95% CI, -0.20 to 0.04], P = .20), or very low birth weight (0.76% to 0.72% [difference: -0.03] vs

30 [95% CI, -0.96 to -0.10], P = .02), and very low birth weight (-0.13 percentage points [95% CI, -0.25

31 e points [95% CI, -0.26 to -0.02], P = .03), low birth weight (-0.53 percentage points [95% CI, -0.96

32 high body mass index, elevated insulin, and low birth weight (1.33 [1.09-1.62]; P = 0.005).

33 factors were 2.88 (95% CI, 2.28 to 3.63) for low birth weight, 1.54 (95% CI, 1.13 to 2.09) for matern

34 9.4%) preterm births, 95 (14.2%) births with low birth weight, 11 (1.7%) spontaneous abortions, and s

35 AS had a significantly higher percentage of low birth weight (35.0% vs. 6.0%; p = 0.006).

36 Prevalence of low birth weight (37.9%, risk ratio [RR] = 12.61; 95% co

37 ; RR, 0.85; 95% CI, 0.80-0.91; P < .001) and low birth weight (40.2 vs 45.7 per 100 live births; RR,

38 ge points [95% CI, -0.05 to 0.02], P = .37), low birth weight (5.41% to 5.36% [difference: -0.05] vs

39 f preterm birth (8% and 7%, respectively) or low birth weight (6% and 4%, respectively).

40 tubes and faecal samples were analysed for a low-birth weight (725 g) neonate EGA 25 weeks in intensi

41 nce odds ratio, 1.15; 95% CI, 0.93 to 1.42), low birth weight (76 cases among 1768 exposed pregnancie

42 1.02, 1.09; P < 0.01), and 9% higher odds of low birth weight (95% CI: 1.02, 1.17; P = 0.01).

43 ociated with several complications including low birth weight, abnormal placentation and increased ri

44 imates were observed for the associations of low birth weight adjusted for gestational age at birth w

45 d significantly increased risks for neonatal low birth weight (adjusted relative risk [aRR] = 3.5; 95

46 sting analysis, and 187,744 children for the low-birth-weight analysis.

47 who were born very preterm and/or with very low birth weight and 106 term-born control subjects from

48 It is well established that low birth weight and accelerated postnatal growth increa

49 Low birth weight and accelerated postnatal growth lead t

50 tabolic diseases increase offspring risk for low birth weight and cardiometabolic diseases in adultho

51 n FGR for explaining the association between low birth weight and cardiovascular risk in adulthood.

52 egnancy outcomes (fetal demise, prematurity, low birth weight and congenital anomaly) in HIV-infected

53 he results show that the association between low birth weight and decreased cognitive ability has dec

54 to infants with risk factors, in addition to low birth weight and early gestational age, reduces the

55 analysis to estimate the association between low birth weight and individuals' IQ scores (IQs).

56 In subgroup analysis by CKD subtype, low birth weight and maternal pregestational DM associat

57 However, low birth weight and maternal smoking were associated wi

58 Such patterns of low birth weight and postnatal catch-up growth have been

59 and fetal HLA-C variants are correlated with low birth weight and pre-eclampsia or high birth weight

60 Low birth weight and preterm birth are associated with a

61 Low birth weight and rapid infant growth in early infanc

62 Low birth weight and rapid postnatal growth increases ri

63 A consistent trend was seen for low birth weight and small-for-gestational-age birth wei

64 Children with low birth weight and smoking mothers had greater caries

65 Gestational hypoxia caused low birth-weight and changes in young adult offspring br

66 ge difference in the prevalence of U between low-birth weight and normal-birth weight children.

67 difference (SD) in cognitive scores between low-birth-weight and normal-birth-weight children was la

68 ong congenitally infected infants, 32.3% had low birth weight, and 30.8% required hospitalization aft

69 legislation, 991 stillbirths, 5,470 cases of low birth weight, and 430 neonatal deaths were prevented

70 3.9% (95%CI 2.6-5.1; p < 0.001) reduction in low birth weight, and a 7.6% (95%CI 3.4-11.7; p = 0.001)

71 presence of additional structural anomalies, low birth weight, and earlier year of birth were the mos

72 ciated with intrauterine growth restriction, low birth weight, and fetal death, but findings are limi

73 verse birth outcomes included preterm birth, low birth weight, and fetal or neonatal death.

74 Preterm birth, low birth weight, and greater infant weight gain were as

75 Preterm birth, low birth weight, and infant catch-up growth seem associ

76 tions, spontaneous abortions, preterm birth, low birth weight, and infant infections) among pregnanci

77 tions, spontaneous abortions, preterm birth, low birth weight, and infections during the first year o

78 In regression models, male sex, low birth weight, and maternal smoking were independent

79 , urban/rural area of domicile, prematurity, low birth weight, and mother's age.

80 weeks, small and large for gestational age, low birth weight, and neonatal intensive care unit admis

81 irth defect, small size for gestational age, low birth weight, and preterm birth.

82 of major congenital anomalies, prematurity, low birth weight, and small size for gestational age obs

83 including septicemia, respiratory distress, low birth weight, and spontaneous preterm birth.

84 orn include intrauterine growth restriction, low birth weight, and stillbirth.

85 ernal anemia, maternal peripheral infection, low birth weight, antenatal clinic (ANC) attendance, and

86 restriction (aOR, 1.17; 95% CI, 1.01-1.37), low birth weight (aOR, 1.91; 95% CI, 1.33-2.76), and fet

87 birth (AOR: 2.22; 95% CI: 1.29-3.79) but not low birth weight (AOR: 1.61; 95% CI: 0.94-2.73).

88 nic-level PM2.5 levels and preterm birth and low birth weight at the individual level, adjusting for

89 h cohort, despite a higher proportion of the low-birth-weight babies having a very low birth weight (

90 y 39 operations associated with 1 additional low birth weight baby, every 25 operations associated wi

91 lementation in preterm (gestation <37 wk) or low-birth-weight (birth weight <2500 g) neonates was con

92 ease, neural tube defects, preterm birth and low birth weight, birth asphyxia, and intracranial hemor

93 h the largest PM2.5 range, preterm birth and low birth weight both were associated with the highest q

94 Evidence for the effects of low birth weight, breastfeeding and maternal smoking on

95 The associations of low birth weight, breastfeeding and maternal smoking wit

96 or PM2.5 concentrations were associated with low birth weight but not preterm birth.

97 Maternal HIV was associated with low birth weight but not stillbirth.

98 ted with reduced rates of pyelonephritis and low birth weights, but the available evidence was not cu

99 Both low birth weight (BW), as a marker of fetal growth restr

100 s-fostered to normally fed dams, demonstrate low birth weight, catch-up growth, and reduced life span

101 who were born very preterm and/or with very low birth weight, cBF volumes were significantly reduced

102 In low-birth-weight children (<2500 g), the RNFL was 3.5 mu

103 strabismus reported by the studies included low birth weight, cicatricial retinopathy of prematurity

104 ey-transplanted mothers born preterm or with low birth weight compared with similar controls.

105 egnancy outcomes (fetal demise, prematurity, low birth weight, congenital anomaly) in pregnant women

106 Such a group comprises premature birth, low-birth-weight, congenital anomalies, perinatal asphyx

107 All extremely low birth weight (ELBW, <1000 g) cases with IC and contr

108 The mean IQs of the extremely low birth weight (ELBW, <1000 g), very low birth weight

109 tational age neonates (ELGAN) with extremely low birth weight (ELBW; <1000 g) participating in a rand

110 Immunization of extremely low-birth-weight (ELBW) infants in the neonatal intensiv

111 early parenteral nutrition (PN) in extremely low-birth-weight (ELBW) infants to promote growth and de

112 ed a retrospective cohort study of extremely low-birth-weight (ELBW; birth weight <1000 g) infants bo

113 alation is associated with preterm delivery, low birth weight, fetal growth retardation and developme

114 Odds of stillbirth, prematurity and low birth weight, frequency and length of hospital admis

115 that FDSLNH might protect infants with very low birth weight from late-onset neonatal sepsis.

116 iddle-income countries are at full term with low birth weight (FT-LBW).

117 In low-birth-weight girls, obesity increases the risk of pr

118 ormal birth weight, mothers of newborns with low birth weight had a 3-fold increased risk of VTE, whi

119 months old between the two groups; however, low birth weight had a negative impact on weight gain in

120 Both maternal smoking during pregnancy and low birth weight have been implicated in impaired develo

121 Adults who were born preterm with a very low birth weight have higher blood pressure and impaired

122 d morbidity (e.g., type 2 diabetes mellitus (low birth weight hazard ratio = 1.79, 95% confidence int

123 k of mortality (e.g., cardiac-related death (low birth weight hazard ratio = 2.69, 95% confidence int

124 eased risk of APOs such as preterm birth and low birth weight in a population-based study in rural In

125 being small for gestational age, and having low birth weight in a second, live-born infant in a coho

126 the association between prenatal smoking and low birth weight in a tissue that is mechanistically rel

127 outcome (stillbirth or spontaneous abortion, low birth weight in an infant, preterm delivery, or cong

128 r-age), wasting (low weight-for-height), and low birth weight in children aged between 0 and 59 mo at

129 pmol/L) was associated with a higher risk of low birth weight in newborns (adjusted risk ratio = 1.15

130 ciated with significantly increased risks of low birth weight in primigravidae (OR, 6.09; 95% CI, 1.1

131 er factors associated with preterm birth and low birth weight included treatment with chemotherapy an

132 r population-based twin cohort revealed that low birth weight increased the risk for development of I

133 deletion phenotype including the persistent low birth weight, increased body weight gain in early ad

134 how that mice lacking Snord116 globally have low birth weight, increased body weight gain, energy exp

135 Very low-birth-weight infant infection rates were 16.4% in 20

136 d moderate anemia, and 1 delivered a preterm low-birth-weight infant.

137 The majority of very low birth weight infants (52%) were discharged on formul

138 remely low birth weight infants than in very low birth weight infants (55.5 +/- 8.3 mum vs. 66.7 +/-

139 ase, pulmonary disease, pre-term delivery of low birth weight infants and metabolic disease.

140 cy is associated with increased frequency of low birth weight infants and neonatal complications, the

141 support by nurses have higher rates of very low birth weight infants discharged home on human milk.

142 between the dependent variable (rate of very low birth weight infants discharged on "any human milk")

143 thickness was 11.2 mum thinner in extremely low birth weight infants than in very low birth weight i

144 Other than in low birth weight infants, adverse effects were rare and

145 r disease, necrotizing enterocolitis in very low birth weight infants, and hepatic encephalopathy.

146 ntion of IC has become a major focus in very low birth weight infants, with fluconazole increasingly

147 a major cause of morbidity and mortality in low birth weight infants.

148 more stressed, such as those with preterm or low birth weight infants.

149 0-3999 g), while the admission rate for very low-birth-weight infants (<1500 g) was 844.1 per 1000 li

150 uble-blind randomized clinical trial in very low-birth-weight infants (birth weight <1500 g) admitted

151 Major surgery in very low-birth-weight infants is independently associated wit

152 yielded similar short-term outcomes in very low-birth-weight infants regarding safety and efficacy w

153 We randomly assigned very preterm or very-low-birth-weight infants to daily milk increments of 30

154 ability at 24 months in very preterm or very-low-birth-weight infants with a strategy of advancing mi

155 the risk of cognitive delay among extremely-low-birth-weight infants with anemia.

156 he past 2 decades on the development of very-low-birth-weight infants' oral feeding skills.

157 In extremely-low-birth-weight infants, a higher hemoglobin threshold

158 harides (HMOs) and late-onset sepsis in very-low-birth-weight infants, and to describe the compositio

159 Among extremely-low-birth-weight infants, the rate of survival to 36 wee

160 use of prophylactic fluconazole in extremely low-birth-weight infants.

161 f chronic lung disease or death in extremely low-birth-weight infants.

162 Low birth weight is a risk factor for cardiovascular dis

163 Low birth weight is a well-established risk factor for t

164 The delivery of a newborn with low birth weight is associated with a 3-fold increased r

165 ligodendrocytes, in preterm babies with very low birth weight is associated with decreased cerebral a

166 Low birth weight is associated with ESRD.

167 Low birth weight is associated with perinatal and long-t

168 ter in life, and animal studies suggest that low birth weight is associated with reduced activity and

169 Low birth weight (LBW) (</=2500 g) is associated with ir

170 associated with disparities in the rates of low birth weight (LBW) and preterm birth (PTB) between w

171 nancy dietary patterns and preterm birth and low birth weight (LBW) are limited and inconsistent.

172 (PTB), small for gestational age (SGA), and low birth weight (LBW) are risk factors for morbidity an

173 uring pregnancy with preterm birth (PTB) and low birth weight (LBW) but disagree over which time fram

174 Individuals with a low birth weight (LBW) have an increased risk of metabol

175 mum in aerodynamic diameter (PM2.5) and term low birth weight (LBW) have resulted in inconsistent fin

176 India, and although this has been linked to low birth weight (LBW) in these populations, the relatio

177 Low birth weight (LBW) is an important public health pro

178 Low birth weight (LBW) is associated with increased risk

179 at home by unskilled attendants, the rate of low birth weight (LBW) is high, and postnatal care is li

180 and the effectiveness of IPTp-SP at reducing low birth weight (LBW) were assessed among human immunod

181 ciated with small for gestational age (SGA), low birth weight (LBW), and preterm birth.

182 ond-hand smoke (SHS) during pregnancy causes low birth weight (LBW), but its mechanism remains unknow

183 Maternal periodontal disease leads to low birth weight (LBW), insulin resistance (IR), increas

184 c OGD exposures and term birth weight (tBW), low birth weight (LBW), preterm birth (PTB), and small f

185 ersity during pregnancy and maternal anemia, low birth weight (LBW), preterm birth (PTB), and stillbi

186 measures of malaria at delivery and risks of low birth weight (LBW), small for gestational age (SGA),

187 nd health, delivery in a health facility and low birth weight (LBW), women's knowledge, and physical

188 200,000 child deaths annually, mainly due to low birth weight (LBW).

189 n the relationship between periodontitis and low birth weight (LBW).

190 PTD), very preterm delivery (VPTD), and term low birth weight (LBW).

191 factors according to presence or absence of low birth weight (LBW, birth weight <2500 g), adjusted C

192 vestigated sex-specific associations between low birth weight (LBW; <2.5 kg) and adult-onset diabetes

193 studies have reported that individuals with low birth weights (LBW, <2500 g) have a lower intelligen

194 Low-birth-weight (LBW) infants are at high risk of stunt

195 onspecific effects; early BCG vaccination of low-birth-weight (LBW) newborns reduces neonatal mortali

196 Associations between low birth weight (</=2,500 g) and increased risk of mort

197 remature birth in conjunction with extremely low birth weight (<1 kg, ELBW) is associated with insuli

198 of the low-birth-weight babies having a very low birth weight (<1,500 g) in the more recent birth coh

199 ation), low birth weight (<2500 g), and very low birth weight (<1500 g).

200 at birth independently increases the risk of low birth weight (<2,500 g) and preterm birth (<37 weeks

201 weeks of gestation) was 6.7% (P = 0.113) and low birth weight (<2,500 g) was 10.2% (P = 1.00).

202 The prevalence of low birth weight (<2500 g) was 12.7%, 13.5%, and 12.1% (

203 reterm birth (gestational age <37 weeks) and low birth weight (<2500 g) with childhood asthma outcome

204 , very preterm birth (<32 weeks' gestation), low birth weight (<2500 g), and very low birth weight (<

205 utcome measures included induction of labor, low birth weight (<2500 g), cesarean section, Apgar scor

206 Birth weight (in grams), low birth weight (<2500 g), preterm delivery (<37 weeks)

207 on on birth weight and secondary outcomes of low birth weight (<2500 g), small for gestational age, b

208 Low birth weight (<2500 g), small for gestational age, o

209 d stillbirth, preterm birth (<37 weeks), and low birth weight (<2500 g).

210 ctive cohort study of mothers and their very-low-birth-weight (<1500 g) infants with >=1 milk sample

211 Malaria causes low birth weight, malnutrition, and inflammation, all of

212 r controlling for known modifiers, including low birth weight, maternal education, seizure disorder,

213 Low birth weight, maternal gestational DM, and maternal

214 birth weight (VLBW, 1000-1499 g), moderately low birth weight (MLBW, 1500-2499 g) and NBW individuals

215 95% CI 1.04-2.00; p = 0.026) but not preterm/low-birth-weight neonates (aOR 1.30; 95% CI 0.76-2.23; p

216 obiotic formulations on outcomes of preterm, low-birth-weight neonates, we found moderate to high evi

217 tic formulations on the outcomes of preterm, low-birth-weight neonates.

218 ty, and poor maternal-fetal outcomes such as low-birth-weight newborns.

219 with preterm birth, but was associated with low birth weight [odds ratio (OR) = 1.22; 95% CI: 1.07,

220 nal protein restriction was used to generate low-birth-weight offspring that underwent accelerated po

221 lationship between advanced maternal age and low birth weight or preterm birth is statistically and s

222 ntly associated with differences in rates of low birth weight or preterm birth outcomes overall, alth

223 ot independently associated with the risk of low birth weight or preterm delivery among mothers who h

224 95% CI, 1.25-1.94; 14 studies; I2, 39%) and low birth weight (OR, 1.96; 95% CI, 1.24-3.10; 8 studies

225 (odds ratio [OR], 2.45; 95% CI, 1.36-4.40), low birth weight (OR, 3.41; 95% CI, 1.61-7.26), and use

226 erm birth (OR: 2.36; 95% CI: 1.54-3.62), and low birth weight (OR: 2.00; 95% CI: 1.24-3.23) were foun

227 nce of the polymorphism on parasite density, low birth weight, or preterm delivery was discernible.

228 ngth (P < 0.05) and reduced the incidence of low birth weight (P < 0.01).

229 ight (P < 0.05) and reduced the incidence of low birth weight (P = 0.01).

230 = 0.040), with a trend toward differences in low birth weight (P = 0.069).

231 and a restricted subcohort of preterm, very low birth weight (P-VLBW) infants.

232 le periodontitis-related bacteria in preterm low birth weight (PLBW) delivery, we recruited 90 pregna

233 ystone pathogens are associated with preterm low birth weight (PLBW).

234 alence ratio [PR], 1.52; 95% CI, 1.34-1.71), low birth weight (PR, 1.59; 95% CI, 1.38-1.83), and cesa

235 Low birth weight predicts compromised cognitive ability.

236 tal infections, candidemia, bacteremia, very low birth weight, prematurity, respiratory disorders, an

237 multicentered clinical trial found that very low-birth weight preterm infants given bovine lactoferri

238 le of African-American and European-American low-birth-weight preterm infants.

239 after adjusting for sex, parental education, low birth weight, preterm birth, parental social class,

240 Orofacial cleft, low birth weight, preterm delivery, fetal death, low Apg

241 ax increases also reduced the risk of having low-birth-weight, preterm, and small-for-gestational-age

242 R], 0.24 [95% CI, 0.14-0.40]; 12 trials) and low birth weight (range, 2.5%-14.8% for the intervention

243 = 1.99; CI: 1.06, 3.72 for preterm birth and low birth weight, respectively, for PM2.5 >/= 36.5 mug/m

244 ositive RDT findings may potentially prevent low birth weight resulting from malaria.

245 Low birth weight (rho = -0.155; P = .015) and childhood

246 BMIZ (+0.21; P = 0.035) and a lower risk of low birth weight (RR: 0.61, 95% CI: 0.39, 0.96; P = 0.03

247 psia, stroke, stillbirth, preterm birth, and low birth weight; screening and risk prediction test per

248 ailable evidence taken together, the risk of low birth weight seems to correlate with the quantity of

249 Primary health outcomes are low birth weight, severe pneumonia incidence, stunting i

250 Children with low birth weight should be given priority as this is a r

251 Main outcomes included birth weight, low birth weight, small for gestational age at birth; he

252 There were no significant differences in low birth weight, small for gestational age, birth lengt

253 For other birth outcomes (low birth weight, small for gestational age, stillbirth,

254 reterm birth, gestational diabetes mellitus, low birth weight, small-for-gestational-age birth, still

255 Prevalence of preterm birth, low birth weight, small-for-gestational-age births, cesa

256 ppear to influence the risks of prematurity, low birth weight, small-for-gestational-age or fetal dea

257 ce of ZIKV on the prevalence of prematurity, low birth weight, small-for-gestational-age, and fetal d

258 ociated with increased risks of prematurity, low birth weight, small-for-gestational-age, or fetal de

259 .40; P < 0.01] and reducing the incidence of low birth weight (SMD: -0.22; 95% CI: -0.37, -0.06; P <

260 se reproductive/developmental effects, e.g., low birth weight, spontaneous abortion, stillbirth, and

261 though genetics, maternal undernutrition and low birth weight status certainly play a role in child g

262 to be mediated largely by factors other than low-birth-weight status.

263 nked with adverse pregnancy outcomes such as low birth weight, stillbirth, and prematurity.

264 te that early vascular dysfunction occurs in low-birth-weight subjects, especially preterm (PT) infan

265 have an increased risk of preterm birth and low birth weight, suggesting that additional surveillanc

266 tion of patent infections at enrollment with low birth weight suggests the importance of preventing P

267 ly reported that the transition of extremely low-birth-weight survivors (</=1000 g) in their mid-20s

268 2011, and August 13, 2013, among 100 of 165 low-birth-weight survivors (60.6%) prematurely born betw

269 In the fourth decade of life, extremely low-birth-weight survivors achieved similar educational

270 rticipants included 100 (39 males) extremely low-birth-weight survivors and 89 (33 males) normal-birt

271 othetical intervention where no infants were low birth weight, the adjusted controlled direct effect

272 with either continuous birth weight or term low birth weight (TLBW) risk, we primarily relied on the

273 n the incidence of preterm birth (PTB), term low birth weight (TLBW), autism spectrum disorder (ASD),

274 ROP in our study were: low gestational age, low birth weight, type of multiple gestation, the presen

275 Among neonates: low birth weight, use of minor respiratory interventions

276 sis more frequent in mothers with preterm or low-birth weight versus normal delivery.

277 Low birth weight, very low birth weight (VLBW), preterm

278 infants born very preterm (VPT) or with very low birth weight (VLBW) is necessary to guide clinical m

279 eterm (VPT) at 32 weeks or less or with very low birth weight (VLBW) of 1250 g or less.

280 Low birth weight, very low birth weight (VLBW), preterm birth, and very preterm

281 emely low birth weight (ELBW, <1000 g), very low birth weight (VLBW, 1000-1499 g), moderately low bir

282 s represent a high-risk subgroup of the very low-birth-weight (VLBW) (<1500 g) population that would

283 vement (CQI) projects aimed at reducing very low-birth-weight (VLBW) infant morbidities.

284 ia (BPD) remains a serious morbidity in very low-birth-weight (VLBW) infants (<1500 g).

285 f antibiotic use among all hospitalized very low-birth-weight (VLBW) infants across Canada and the as

286 typically benign in term infants but in very low-birth-weight (VLBW) infants can cause pneumonitis an

287 pment, growth, and feeding tolerance in very-low-birth-weight (VLBW) infants fed an exclusively human

288 The annual volume of deliveries of very low-birth-weight (VLBW) infants has a greater effect on

289 Recent nutritional research in very-low-birth-weight (VLBW) infants is focused on the preven

290 Importance: For many very low-birth-weight (VLBW) infants, there is insufficient m

291 cular hemorrhage (IVH) are common among very-low-birth-weight (VLBW) infants.

292 ause serious morbidity and mortality in very low-birth-weight (VLBW) infants.

293 udy from January 2010 to February 2014, very low-birth-weight (VLBW, </=1500 g) infants, within 5 day

294 in combination to affect the growth of very-low-birth-weight (VLBW, <1500 g) infants are limited.

295 who were born very preterm and/or with very low birth weight was specifically associated with both n

296 to maternal smoking during uterine life and low birth weight were independently associated with havi

297 l for gestational age, preterm delivery, and low birth weight) were evaluated.

298 syndrome is an imprinting disorder involving low birth weight with complex genetics and diagnostics.

299 Our results suggest that low birth weight with rapid postnatal growth results in

300 ons of maternal smoking during pregnancy and low birth weight with retinal nerve fiber layer (RNFL) t